[HTML][HTML] CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells
CTL-associated antigen 4 (CTLA4) blockade releases inhibitory controls on T cell activation
and proliferation, inducing antitumor immunity in both preclinical and early clinical trials. We …
and proliferation, inducing antitumor immunity in both preclinical and early clinical trials. We …
CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells
SA Quezada, KS Peggs, MA Curran… - Journal of Clinical …, 2006 - search.proquest.com
Abstract CTL-associated antigen 4 (CTLA4) blockade releases inhibitory controls on T cell
activation and proliferation, inducing antitumor immunity in both preclinical and early clinical …
activation and proliferation, inducing antitumor immunity in both preclinical and early clinical …
CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells
SA Quezada, KS Peggs… - Journal of Clinical …, 2006 - mdanderson.elsevierpure.com
Abstract CTL-associated antigen 4 (CTLA4) blockade releases inhibitory controls on T cell
activation and proliferation, inducing antitumor immunity in both preclinical and early clinical …
activation and proliferation, inducing antitumor immunity in both preclinical and early clinical …
[PDF][PDF] CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells
SA Quezada, KS Peggs, MA Curran, JP Allison - Am Soc Clin Investig
CTL-associated antigen 4 (CTLA4) blockade releases inhibitory controls on T cell activation
and proliferation, inducing antitumor immunity in both preclinical and early clinical trials. We …
and proliferation, inducing antitumor immunity in both preclinical and early clinical trials. We …
[HTML][HTML] CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells
SA Quezada, KS Peggs, MA Curran… - Journal of Clinical …, 2006 - ncbi.nlm.nih.gov
Abstract CTL-associated antigen 4 (CTLA4) blockade releases inhibitory controls on T cell
activation and proliferation, inducing antitumor immunity in both preclinical and early clinical …
activation and proliferation, inducing antitumor immunity in both preclinical and early clinical …
CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells
SA Quezada, KS Peggs… - The Journal of …, 2006 - pubmed.ncbi.nlm.nih.gov
CTL-associated antigen 4 (CTLA4) blockade releases inhibitory controls on T cell activation
and proliferation, inducing antitumor immunity in both preclinical and early clinical trials. We …
and proliferation, inducing antitumor immunity in both preclinical and early clinical trials. We …
CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells
SA Quezada, KS Peggs, MA Curran, JP Allison - J CLIN INVEST, 2006 - discovery.ucl.ac.uk
CTL-associated antigen 4 (CTLA4) blockade releases inhibitory controls on T cell activation
and proliferation, inducing antitumor immunity in both preclinical and early clinical trials. We …
and proliferation, inducing antitumor immunity in both preclinical and early clinical trials. We …
[PDF][PDF] CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells
SA Quezada, KS Peggs, MA Curran, JP Allison - researchgate.net
CTL-associated antigen 4 (CTLA4) blockade releases inhibitory controls on T cell activation
and proliferation, inducing antitumor immunity in both preclinical and early clinical trials. We …
and proliferation, inducing antitumor immunity in both preclinical and early clinical trials. We …
[PDF][PDF] CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells
SA Quezada, KS Peggs, MA Curran, JP Allison - core.ac.uk
CTL-associated antigen 4 (CTLA4) blockade releases inhibitory controls on T cell activation
and proliferation, inducing antitumor immunity in both preclinical and early clinical trials. We …
and proliferation, inducing antitumor immunity in both preclinical and early clinical trials. We …
[引用][C] CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells
SA Quezada - Journal of Clinical Investigation, 2006 - cir.nii.ac.jp
CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of
effector and regulatory T cells | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲ恁縖サイニィ …
effector and regulatory T cells | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲ恁縖サイニィ …